Arrow Dx’s Post

🛑 Did you know? Non-alcoholic fatty liver disease (NAFLD/MAFLD) affects 30% of the U.S. population - that’s approximately 1 in 3 adults. This condition is often asymptomatic in its early stages, making it hard to detect. At Arrow Dx, we’re innovating tools to make early detection of conditions like NAFLD/MAFLD easier, more affordable, and accessible to everyone. 💡 Learn more about the importance of early detection: https://bit.ly/3NaYedg

To view or add a comment, sign in

Explore topics